![]() |
By Evelyn Pringle (about the author) Page 4 of 4 page(s)
"Neither health professionals nor consumers," he states, "can accurately provide information about the risk and benefits of a drug like Zyprexa - or any drug for any condition - without a comprehensive awareness of the risks and benefits."
"If the clinical research data regarding effectiveness, efficacy or safety is sequestered or misrepresented from observation studies, randomized drug trials or meta-analyses," he says, "then it is not possible for any provider to give any patient what he or she needs to make an informed consent."
"At that point," Dr Kruszewski says, "individuals receive drugs that may or may not help them, but always at their own peril."
"Zyprexa causes both a severe metabolic syndrome consisting of obesity, diabetes and cardiovascular problems," Dr Kruszewski advises, "at the same time that it continues to cause neurological side-effects like the older antipsychotics."
"Zyprexa and its antipsychotics cousins," he explains, "were marketed to be safer and easier to tolerate because the pharmaceutical companies said that the newer drugs caused fewer neurological injuries, like restlessness or 'akathesia,' and tardive dyskinesia."
Those assertions are false he says, and "what we have now is a drug whose massive revenues and promotion are based upon faulty disclosures by Eli Lilly."
Information for injured parties can be found at Lawyers and Settlements.com http://www.lawyersandsettlements.com/
Evelyn Pringle
evelyn-pringle@sbcglobal.net
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
Contact Author |
Contact Editor |
View Authors' Articles |
| 2 comments |
Want to post your own comment on this Article?
|
||||
Tell a Friend:
|
Copyright © 2002-2009, OpEdNews |